NURS 5334 QUIZ 5: FLUOROQUINOLONES, FOLATE ANTAGONISTS &
URINARY ANTISEPTICS QUESTIONS AND CORRECT ANSWERS PLUS
RATIONALE NEW UPDATE 2026-2027 UTA
98 QUESTIONS
TABLE OF CONTENTS
# TOPIC
1 Differentiate the spectrum of activity, resistance mechanisms, and appropriate clinical indications for each
generation of fluoroquinolones
2 Analyze the pharmacologic basis for folate antagonism and predict hematologic and teratogenic
consequences of therapy
3 Evaluate drug-drug interactions, Black Box warnings, and monitoring parameters for urinary antiseptics
and related agents
4 Synthesize current evidence-based guidelines to select, adjust, or discontinue antimicrobial therapy in
complex clinical scenarios
5 NURS 5334 Quiz 5
6 Fluoroquinolones
7 Folate Antagonists & Urinary Antiseptics Questions and Correct Answers plus Rationale New Update
2026
8 2027 UTA
9 Foundations of Advanced Pharmacology - Fluoroquinolones, Folate Antagonists, and Urinary Antiseptics
10 Applied Advanced Pharmacology - Fluoroquinolones, Folate Antagonists, and Urinary Antiseptics
11 Advanced Advanced Pharmacology - Fluoroquinolones, Folate Antagonists, and Urinary Antiseptics
12 Advanced Pharmacology - Fluoroquinolones, Folate Antagonists, and Urinary Antiseptics Review
ABSTRACT
Page 1
,This study document brings together 98 carefully worded exam questions drawn from NURS 5334
Quiz 5: Fluoroquinolones, Folate Antagonists & Urinary Antiseptics Questions and Correct
Answers plus Rationale New Update 2026-2027 UTA, with the strongest emphasis placed on
Differentiate the spectrum of activity, resistance mechanisms, and appropriate clinical indications
for each generation of fluoroquinolones, Analyze the pharmacologic basis for folate antagonism
and predict hematologic and teratogenic consequences of therapy, Evaluate drug-drug interactions,
Black Box warnings and and monitoring parameters for urinary antiseptics and related agents.
Every item follows the wording style and level of reasoning you meet in the real paper, and each
one is paired with a clear rationale so the correct choice is never a guess. Work through the set at
your own pace, mark the questions that slow you down, then come back to them until the
reasoning feels automatic. Learners who revise this way walk into the exam room recognising the
pattern behind the questions instead of meeting them for the first time. Keep going - steady, honest
practice is what turns a difficult paper into a comfortable pass.
Q1 DIFFERENTIATE THE SPECTRUM OF ACTIVITY, RESISTANCE MECHANISMS, AND
APPROPRIATE CLINICAL INDICATIONS FOR EACH GENERATION OF FLUOROQUINOLONES
A patient with a documented QT interval of 510 ms and a history of torsades de
pointes is prescribed a fluoroquinolone for a complicated urinary tract infection.
Which agent poses the greatest additional risk of QT prolongation and should be
avoided?
A. Ciprofloxacin
B. Levofloxacin
C. Moxifloxacin CORRECT
D. Ofloxacin
RATIONALE: Moxifloxacin carries the strongest QT-prolongation signal among fluoroquinolones
and is contraindicated in patients with baseline QT prolongation or a history of torsades.
Levofloxacin and ciprofloxacin have moderate risk, while ofloxacin has comparatively lower risk;
however, all fluoroquinolones should be used cautiously in this scenario.
Page 2
,Q2 DIFFERENTIATE THE SPECTRUM OF ACTIVITY, RESISTANCE MECHANISMS, AND
APPROPRIATE CLINICAL INDICATIONS FOR EACH GENERATION OF FLUOROQUINOLONES
Which statement best explains why trimethoprim is often combined with
sulfamethoxazole in clinical practice?
A. The combination expands coverage to Pseudomonas aeruginosa.
B. Sequential blockade of the folate synthesis pathway produces synergistic bactericidal activity.
CORRECT
C. Sulfamethoxazole prevents the renal excretion of trimethoprim.
D. Trimethoprim inactivates beta-lactamases produced by resistant organisms.
RATIONALE: Trimethoprim inhibits dihydrofolate reductase, while sulfamethoxazole inhibits
dihydropteroate synthase, blocking two consecutive steps in bacterial folate synthesis and
producing synergistic bacteriostatic to bactericidal effects. The combination does not extend
coverage to Pseudomonas, does not affect renal excretion, and has no beta-lactamase inhibitory
activity.
Q3 DIFFERENTIATE THE SPECTRUM OF ACTIVITY, RESISTANCE MECHANISMS, AND
APPROPRIATE CLINICAL INDICATIONS FOR EACH GENERATION OF FLUOROQUINOLONES
A patient on warfarin is prescribed nitrofurantoin for an uncomplicated lower
urinary tract infection. Which monitoring parameter is most critical to assess
within the first week of combined therapy?
A. Serum creatinine and BUN
B. International normalized ratio (INR) CORRECT
C. Complete blood count with differential
D. Liver function tests
RATIONALE: Nitrofurantoin can potentiate the anticoagulant effect of warfarin, likely through
inhibition of CYP2C9-mediated metabolism or alterations in gut flora producing vitamin K,
necessitating close INR monitoring. While renal and hematologic parameters are relevant for
nitrofurantoin toxicity, the most immediate and dangerous interaction is the elevated bleeding risk
reflected by INR.
Page 3
, Q4 DIFFERENTIATE THE SPECTRUM OF ACTIVITY, RESISTANCE MECHANISMS, AND
APPROPRIATE CLINICAL INDICATIONS FOR EACH GENERATION OF FLUOROQUINOLONES
Which fluoroquinolone characteristic most directly accounts for its efficacy
against intracellular pathogens such as Legionella pneumophila?
A. High oral bioavailability
B. Concentration-dependent bactericidal activity
C. Excellent penetration into alveolar macrophages and phagocytes CORRECT
D. Inhibition of topoisomerase IV rather than DNA gyrase
RATIONALE: Fluoroquinolones achieve high intracellular concentrations within macrophages and
neutrophils, which is essential for eradicating facultative intracellular organisms like Legionella.
While bioavailability and concentration-dependent killing contribute to efficacy, the ability to
penetrate phagocytes is the most direct determinant of activity against intracellular pathogens.
Q5 DIFFERENTIATE THE SPECTRUM OF ACTIVITY, RESISTANCE MECHANISMS, AND
APPROPRIATE CLINICAL INDICATIONS FOR EACH GENERATION OF FLUOROQUINOLONES
A patient with G6PD deficiency is prescribed dapsone for dermatitis herpetiformis.
Which adverse effect is most directly attributable to the patient's enzyme
deficiency?
A. Methemoglobinemia and hemolytic anemia CORRECT
B. Agranulocytosis
C. Aplastic anemia
D. Megaloblastic anemia
RATIONALE: Dapsone, like other oxidant drugs, can precipitate methemoglobinemia and
hemolytic anemia in G6PD-deficient individuals due to impaired regeneration of NADPH and
reduced glutathione. Agranulocytosis and aplastic anemia are idiosyncratic reactions not directly
linked to G6PD status, and megaloblastic anemia is typically associated with folate or B12
deficiency.
Page 4
URINARY ANTISEPTICS QUESTIONS AND CORRECT ANSWERS PLUS
RATIONALE NEW UPDATE 2026-2027 UTA
98 QUESTIONS
TABLE OF CONTENTS
# TOPIC
1 Differentiate the spectrum of activity, resistance mechanisms, and appropriate clinical indications for each
generation of fluoroquinolones
2 Analyze the pharmacologic basis for folate antagonism and predict hematologic and teratogenic
consequences of therapy
3 Evaluate drug-drug interactions, Black Box warnings, and monitoring parameters for urinary antiseptics
and related agents
4 Synthesize current evidence-based guidelines to select, adjust, or discontinue antimicrobial therapy in
complex clinical scenarios
5 NURS 5334 Quiz 5
6 Fluoroquinolones
7 Folate Antagonists & Urinary Antiseptics Questions and Correct Answers plus Rationale New Update
2026
8 2027 UTA
9 Foundations of Advanced Pharmacology - Fluoroquinolones, Folate Antagonists, and Urinary Antiseptics
10 Applied Advanced Pharmacology - Fluoroquinolones, Folate Antagonists, and Urinary Antiseptics
11 Advanced Advanced Pharmacology - Fluoroquinolones, Folate Antagonists, and Urinary Antiseptics
12 Advanced Pharmacology - Fluoroquinolones, Folate Antagonists, and Urinary Antiseptics Review
ABSTRACT
Page 1
,This study document brings together 98 carefully worded exam questions drawn from NURS 5334
Quiz 5: Fluoroquinolones, Folate Antagonists & Urinary Antiseptics Questions and Correct
Answers plus Rationale New Update 2026-2027 UTA, with the strongest emphasis placed on
Differentiate the spectrum of activity, resistance mechanisms, and appropriate clinical indications
for each generation of fluoroquinolones, Analyze the pharmacologic basis for folate antagonism
and predict hematologic and teratogenic consequences of therapy, Evaluate drug-drug interactions,
Black Box warnings and and monitoring parameters for urinary antiseptics and related agents.
Every item follows the wording style and level of reasoning you meet in the real paper, and each
one is paired with a clear rationale so the correct choice is never a guess. Work through the set at
your own pace, mark the questions that slow you down, then come back to them until the
reasoning feels automatic. Learners who revise this way walk into the exam room recognising the
pattern behind the questions instead of meeting them for the first time. Keep going - steady, honest
practice is what turns a difficult paper into a comfortable pass.
Q1 DIFFERENTIATE THE SPECTRUM OF ACTIVITY, RESISTANCE MECHANISMS, AND
APPROPRIATE CLINICAL INDICATIONS FOR EACH GENERATION OF FLUOROQUINOLONES
A patient with a documented QT interval of 510 ms and a history of torsades de
pointes is prescribed a fluoroquinolone for a complicated urinary tract infection.
Which agent poses the greatest additional risk of QT prolongation and should be
avoided?
A. Ciprofloxacin
B. Levofloxacin
C. Moxifloxacin CORRECT
D. Ofloxacin
RATIONALE: Moxifloxacin carries the strongest QT-prolongation signal among fluoroquinolones
and is contraindicated in patients with baseline QT prolongation or a history of torsades.
Levofloxacin and ciprofloxacin have moderate risk, while ofloxacin has comparatively lower risk;
however, all fluoroquinolones should be used cautiously in this scenario.
Page 2
,Q2 DIFFERENTIATE THE SPECTRUM OF ACTIVITY, RESISTANCE MECHANISMS, AND
APPROPRIATE CLINICAL INDICATIONS FOR EACH GENERATION OF FLUOROQUINOLONES
Which statement best explains why trimethoprim is often combined with
sulfamethoxazole in clinical practice?
A. The combination expands coverage to Pseudomonas aeruginosa.
B. Sequential blockade of the folate synthesis pathway produces synergistic bactericidal activity.
CORRECT
C. Sulfamethoxazole prevents the renal excretion of trimethoprim.
D. Trimethoprim inactivates beta-lactamases produced by resistant organisms.
RATIONALE: Trimethoprim inhibits dihydrofolate reductase, while sulfamethoxazole inhibits
dihydropteroate synthase, blocking two consecutive steps in bacterial folate synthesis and
producing synergistic bacteriostatic to bactericidal effects. The combination does not extend
coverage to Pseudomonas, does not affect renal excretion, and has no beta-lactamase inhibitory
activity.
Q3 DIFFERENTIATE THE SPECTRUM OF ACTIVITY, RESISTANCE MECHANISMS, AND
APPROPRIATE CLINICAL INDICATIONS FOR EACH GENERATION OF FLUOROQUINOLONES
A patient on warfarin is prescribed nitrofurantoin for an uncomplicated lower
urinary tract infection. Which monitoring parameter is most critical to assess
within the first week of combined therapy?
A. Serum creatinine and BUN
B. International normalized ratio (INR) CORRECT
C. Complete blood count with differential
D. Liver function tests
RATIONALE: Nitrofurantoin can potentiate the anticoagulant effect of warfarin, likely through
inhibition of CYP2C9-mediated metabolism or alterations in gut flora producing vitamin K,
necessitating close INR monitoring. While renal and hematologic parameters are relevant for
nitrofurantoin toxicity, the most immediate and dangerous interaction is the elevated bleeding risk
reflected by INR.
Page 3
, Q4 DIFFERENTIATE THE SPECTRUM OF ACTIVITY, RESISTANCE MECHANISMS, AND
APPROPRIATE CLINICAL INDICATIONS FOR EACH GENERATION OF FLUOROQUINOLONES
Which fluoroquinolone characteristic most directly accounts for its efficacy
against intracellular pathogens such as Legionella pneumophila?
A. High oral bioavailability
B. Concentration-dependent bactericidal activity
C. Excellent penetration into alveolar macrophages and phagocytes CORRECT
D. Inhibition of topoisomerase IV rather than DNA gyrase
RATIONALE: Fluoroquinolones achieve high intracellular concentrations within macrophages and
neutrophils, which is essential for eradicating facultative intracellular organisms like Legionella.
While bioavailability and concentration-dependent killing contribute to efficacy, the ability to
penetrate phagocytes is the most direct determinant of activity against intracellular pathogens.
Q5 DIFFERENTIATE THE SPECTRUM OF ACTIVITY, RESISTANCE MECHANISMS, AND
APPROPRIATE CLINICAL INDICATIONS FOR EACH GENERATION OF FLUOROQUINOLONES
A patient with G6PD deficiency is prescribed dapsone for dermatitis herpetiformis.
Which adverse effect is most directly attributable to the patient's enzyme
deficiency?
A. Methemoglobinemia and hemolytic anemia CORRECT
B. Agranulocytosis
C. Aplastic anemia
D. Megaloblastic anemia
RATIONALE: Dapsone, like other oxidant drugs, can precipitate methemoglobinemia and
hemolytic anemia in G6PD-deficient individuals due to impaired regeneration of NADPH and
reduced glutathione. Agranulocytosis and aplastic anemia are idiosyncratic reactions not directly
linked to G6PD status, and megaloblastic anemia is typically associated with folate or B12
deficiency.
Page 4
